High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: Long-term toxicity and outcomes

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 1, 2003, Pages 201-207

  Firat, Selim ^a   Murray, Kevin ^a   Erickson, Beth ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Dose response; Ovarian cancer; Whole abdominal irradiation

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; DISEASES; IRRADIATION; TUMORS;

PELVIC IRRADIATION;

ONCOLOGY;

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LIVER ENZYME; MELPHALAN;

ABDOMEN; ABDOMINAL HYSTERECTOMY; ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHRONIC TOXICITY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIARRHEA; DYSURIA; FEMALE; FRACTURE; GASTROINTESTINAL TOXICITY; HEPATIC ENCEPHALOPATHY; HIGH RISK POPULATION; HUMAN; IRRADIATION; KIDNEY; LARGE INTESTINE; LEUKOPENIA; LIVER; LIVER TOXICITY; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; NAUSEA; NEPHROTOXICITY; OMENTUM; OVARIECTOMY; OVARY CARCINOMA; PELVIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SMALL INTESTINE; SMALL INTESTINE OBSTRUCTION; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

EID: 0042566079     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00510-8     Document Type: Article

References (35)

1. Alberts D.S., Green S., Hannigan E.V., et al. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide Final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer . J Clin Oncol. 10:1992;706-717.
2. Omura G.A., Bundy B.N., Berek J.S., et al. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma A Gynecology Oncology Group study . J Clin Oncol. 7:1989;457-465.
3. Redman J.R., Petroni G.R., Saigo P.E., et al. Prognostic factors in advanced ovarian carcinoma. J Clin Oncol. 4:1986;515-523.
4. Klaasen D., Shelley W., Starreveld A., et al. Early stage ovarian cancer A randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate - A National Cancer Institute of Canada Clinical Trials Group Report . J Clin Oncol. 6:1988;1254-1263.
5. Sell A., Bertelsen K., Andersen J.E., et al. Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol. 37:1990;167-373.
6. Chiara S., Conte P.F., Franzone P., et al. High-risk early stage ovarian cancer Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy . Am J Clin Oncol. 17:1994;72-76.
7. Cardenes H., Randall M.E. Integrating radiation therapy in the curative management of ovarian cancer Current issues and future directions . Semin Radiat Oncol. 10:2000;61-70.
8. Herrin V.E., Thigpen J.T. Chemotherapy for ovarian cancer Current concepts . Semin Surg Oncol. 17:1999;181-188.
9. Dembo A.J. Epithelial ovarian cancer The role of radiotherapy . Int J Radiat Oncol Biol Phys. 22:1992;835-845.
10. Hruby G., Bull C.A., Langlands A.O., et al. WART revisited The treatment of epithelial ovarian cancer by whole abdominal radiotherapy . Australas Radiol. 41:1997;276-280.
11. Goldberg N., Peschel R.E. Postoperative abdominopelvic radiation therapy for ovarian cancer. Int J Radiat Oncol Biol Phys. 14:1988;425-429.
12. Lindner H., Willich H., Atzinger A. Primary adjuvant whole abdominal irradiation in ovarian carcinoma. Int J Radiat Oncol Biol Phys. 19:1990;1203-1206.
13. Macbeth F.R., MacDonald H., Williams C.J. Total abdominal and pelvic radiotherapy in the management of early stage ovarian carcinoma. Int J Radiat Oncol Biol Phys. 15:1988;353-358.
14. Dembo A.J., Van Dyk J., Japp B., et al. Whole abdominal irradiation by a moving-strip technique for patients with ovarian cancer. Int J Radiat Oncol Biol Phys. 5:1979;1933-1942.
15. Martinez A., Schray M.F., Howes A.E., et al. Postoperative radiation therapy for epithelial ovarian cancer The curative role based on a 24-year experience . J Clin Oncol. 3:1985;901-911.
16. Einhorn N., Lundell M., Nilsson B., et al. Is there a place for radiotherapy in the treatment of advanced ovarian cancer? Radiother Oncol. 53:1999;213-218.
17. Dembo A.J. Abdominopelvic radiotherapy in ovarian cancer A 10-year experience . Cancer. 55:1985;2285-2290.
18. Petereit G.T., Sharda S.S., Hollister T.C., et al. Adjuvant whole abdominal radiation for low risk and intermediate risk (Dembo classification) ovarian cancer [Abstract]. Gynecol Oncol. 64:1997;339.
19. Vogl S.E., Pagano M., Kaplan B.H., et al. Cis-platin based combination chemotherapy for advanced ovarian cancer High overall response rate with curative potential only in women with small tumor burdens . Cancer. 51:1983;2024-2030.
20. McGuire W.P., Hoskins W.J., Brady M.F., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 334:1996;1-6.
21. Stuart G., Bertelsen K., Mangioni C., et al. Updated analysis shows a highly significant improved overall survival for cisplatin-paclitaxel as first line treatment of advanced ovarian cancer Mature results of the EORTC-GCCG, NOCOVS, NCI-C CTG and Scottish intergroup trial [Abstract] . Proc Am Soc Clin Oncol. 17:1998;361.
22. Adelson M.D., Wharton J.T., Delclos L., et al. Palliative radiotherapy for ovarian cancer. Int J Radiat Oncol Biol Phys. 13:1987;17-21.
23. Firat S., Erickson B. Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum. Gynecol Oncol. 80:2001;213-220.
24. Hoskins W.J., McGuire W.P., Brady M.F., et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 170:1994;974-979.
25. Vergote I.B., Vergote-De Vos L.N., Abeler V.M., et al. Randomized trial comparing cisplatin with radioactive phosphorus or whole abdomen irradiation as adjuvant treatment of ovarian cancer. Cancer. 69:1992;741-749.
26. Wong R., Milosevic M., Sturgeon J., et al. Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy Results of a prospective treatment protocol . Int J Radiat Oncol Biol Phys. 45:1999;657-665.
27. Chiara S., Mammoliti S., Oliva C., et al. Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer A 7 year experience . Eur J Cancer. 27:1991;1211-1215.
28. Wils J., Van Geuns H. Chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Am J Clin Oncol. 12:1989;251-254.
29. Piver M.S., Malfetano J., Hempling R.E., et al. Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma A preliminary report . Gynecol Oncol. 39:1990;249-252.
30. Fyles A.W., Thomas G.M., Pintilie M., et al. A randomized study of two doses of abdominopelvic radiation therapy for patients with optimally debulked stage I, II, and III ovarian cancer. Int Radiat Oncol Biol Phys. 41:1998;543-549.
31. Fuller D.B., Sause W.T., Plenk H.P., et al. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. J Clin Oncol. 5:1987;897-905.
32. Fyles A.W., Dembo A.J., Bush R.S., et al. Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int J Radiat Oncol Biol Phys. 22:1992;847-851.
33. Schray M.F., Martinez A., Howes A.E. Toxicity of open-field whole abdominal irradiation as primary postoperative treatment in gynecologic malignancy. Int J Radiat Oncol Biol Phys. 16:1989;397-403.
34. Weiser E.B., Burke T.W., Heller P.B., et al. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). Gynecol Oncol. 30:1988;201-208.
35. Whelan T.J., Dembo A.J., Bush R.S., et al. Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. Int J Radiat Oncol Biol Phys. 22:1992;853-858.